Code Biotherapeutics
formerly Code BioPioneering Targeted Delivery of Genetic Medicines
Code Biotherapeutics was founded in 2021, is headquartered in Hatfield, United States, lists 11–50 employees, and has $85.0M in recorded funding across 2 rounds.
- Headquarters
- Hatfield, Pennsylvania
- Employees
- 11–50
- Founded
- 2021
- Business Model
- B2B
- Website
- codebiotx.com
- Total Funding
- $85.0M
- Last Round
- $75.0M Series AJun 2022
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds and 6 investors for this company. The full record is or through the API.
About
Code Biotherapeutics is a preclinical-stage genetic medicine company developing transformational non-viral delivery of genetic medicines using its proprietary 3DNA® platform. The 3DNA platform is a multivalent synthetic DNA scaffold engineered to overcome key challenges in genetic medicine delivery including dose-related toxicity and immunogenicity. Code Bio's most advanced program targets Duchenne Muscular Dystrophy.
Summary
Code Biotherapeutics is a Biotech company based in Hatfield, United States, founded in 2021. It lists 11–50 employees. It has raised $85.0M in total across 2 rounds, most recently a $75.0M Series A round in Jun 2022. Investors include 4BIO Capital, Northpond Ventures and Amgen.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jun 2022
Sign up to see all 2 events
Funding: Seed through Series A. Amounts, valuations, and investors where available.
Investors
Similar Companies
Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/code-biotherapeutics"><img src="https://indexed.vc/api/badge/company/code-biotherapeutics" alt="Code Biotherapeutics on Indexed.vc" width="260" height="76" /></a>